CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Remepy Publishes New Evidence Showing its Hybrid Drug, HybridopaTM, Effect on Structural Connectivity in the Brain of Parkinson’s Patients Associated with Improved Clinical Outcome

These findings further strengthen the mechanistic and translational rationale of [...]

By |2026-07-01T12:04:30+00:00July 1, 2026|3rd Party Medical Device Industry News|Comments Off on Remepy Publishes New Evidence Showing its Hybrid Drug, HybridopaTM, Effect on Structural Connectivity in the Brain of Parkinson’s Patients Associated with Improved Clinical Outcome

Paragonix Technologies Announces Launch of CONCERT-DCD Clinical Trial in Collaboration with UW Medicine to Maximize Heart Transplant Utilization

Prospective, multicenter trial will evaluate a novel preservation technique utilizing [...]

By |2026-05-28T00:17:34+00:00May 28, 2026|3rd Party Medical Device Industry News|Comments Off on Paragonix Technologies Announces Launch of CONCERT-DCD Clinical Trial in Collaboration with UW Medicine to Maximize Heart Transplant Utilization
Go to Top